N76-1, a novel CDK7 inhibitor, exhibits potent anti-cancer effects in triple negative breast cancer.
Zhang L, Wu L, Zhou D, Wang G, Chen B, Shen Z, Li X, Wu Q, Qu N, Wu Y, Yuan L, Gan Z, Zhou W.
Zhang L, et al. Among authors: yuan l.
Eur J Pharmacol. 2023 Sep 15;955:175892. doi: 10.1016/j.ejphar.2023.175892. Epub 2023 Jul 8.
Eur J Pharmacol. 2023.
PMID: 37429520
Free article.